restor3D announces completed acquisition of Conformis
Click Here to Manage Email Alerts
Key takeaways:
- restor3d Inc. has announced the completed acquisition of Conformis Inc.
- Conformis stock was removed from trading on the NASDAQ on Sept. 5.
restor3d Inc. has announced the completed acquisition of Conformis Inc. following restor3d stockholder approval, according to a press release.
Common stock of Conformis ceased trading on the NASDAQ on Sept. 5, according to the release.
“We are extremely excited to complete this important transaction and look forward to leveraging our combined portfolio to deliver personalized orthopedic solutions for the whole human body,” J. Kurt Jacobus, CEO of restor3d, said in the release. “With the addition of Conformis to the organization, we see tremendous opportunity to deliver clinically differentiated and cost-effective solutions across the orthopedic landscape, including shoulder, foot [and] ankle, spine and large joints, such as knees and hips. We have mapped out a product roadmap that will deepen and extend our offerings across the body, providing surgeons and patients with the personalized device solutions they deserve,” Jacobus said.
Read more about
Click Here to Manage Email Alerts